1st Quarter - Report

IPOLICY SOLUTIONS for TWIST BIOSCIENCE CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Synthetic positive controls for COVID-19

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Science/Technology SCI

H.R.4373 - Engineering Biology Research and Development Act of 2019 Biosecurity standards American competitiveness

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4373 (116th)

Budget/Appropriations BUD

No bill #, Labor, HHS, Education and Related Agencies Appropriations FY21

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.